| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Departments of Clinical Investigation [M. W., W. N. H., D. L., M. C. A.], Gastrointestinal Medical Oncology and Digestive Diseases [J. L. A.], and Surgical Oncology [D. B. E., P. C.], The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, and Department of Visceral and Transplantation Surgery, University of Bern, Inselspital, Bern, Switzerland [H. F.]
Pancreas cancer is the fourth and fifth leading cause of cancer death for men and women, respectively, in the United States. Although the etiology of this cancer is poorly understood, smoking and dietary fat have been implicated by epidemiological studies. To test the hypothesis that DNA damage derived from carcinogen exposure and diet is involved in pancreatic carcinogenesis, aromatic and lipid peroxidation-related DNA adducts in 13 normal tissues adjacent to tumor and 20 tumors from pancreatic cancer patients were analyzed by 32P-postlabeling. Normal pancreatic tissues from 5 nonpancreatic cancer patients and 19 healthy organ donors served as controls. To correlate the DNA adduct level with patients' characteristics, information on age, sex, body mass index, and smoking status of pancreatic cancer patients were collected from medical records. A significantly higher level of total DNA adducts was detected in pancreatic cancer patients as compared with controls. The mean level of adducts/108 nucleotides in adjacent normal pancreatic tissues from pancreatic cancer patients (A tissues) was 102 ± 21 compared with 39 ± 6 and 13 ± 1 in pancreatic tumor tissues (T tissues) and normal pancreatic tissues from controls (C tissues), respectively. Among the adducts observed, one single aromatic adduct (spot 1) was present in 100, 90, and 0% of the A, T, and C tissues, respectively. Two novel clusters of adducts (spots 2 and 3) were observed in 11 of 13, 12 of 20, and 2 of 24 of A, T, and C tissues, respectively, and the presence of these adducts was positively correlated with smoking status. In addition, the previously defined smoking-related diagonal radioactive zone was detected in three A samples only, although 50% (10 of 20) of the patients with pancreatic cancers in this study were ever smokers. Putative lipid peroxidation-related adducts were detected in all samples examined and were significantly higher in A than in T and C samples. Multiple regression analyses showed that body mass index was positively correlated to the levels of spot 1 and the lipid peroxidation-related adducts in A tissues and the total aromatic adducts in tumors. Smoking was also positively correlated to the level of total adducts. These observations are consistent with previous epidemiological findings and support the hypothesis that DNA damage related to carcinogen exposure and lipid peroxidation is involved in human pancreatic carcinogenesis.
1 This investigation was in part supported by a grant from The University of Texas M. D. Anderson Cancer Center Physicians Referral Service.
2 To whom requests for reprints should be addressed, at Department of Clinical Investigation, Box 19, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030.
Received 9/23/97. Accepted 11/12/97.
This article has been cited by other articles:
![]() |
S. Rohrmann, S.-U. Lukas Jung, J. Linseisen, and W. Pfau Dietary intake of meat and meat-derived heterocyclic aromatic amines and their correlation with DNA adducts in female breast tissue Mutagenesis, March 1, 2009; 24(2): 127 - 132. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Lei, M. Abdelrahim, S. D. Cho, X. Liu, and S. Safe Structure-dependent activation of endoplasmic reticulum stress-mediated apoptosis in pancreatic cancer by 1,1-bis(3'-indoly)-1-(p-substituted phenyl)methanes Mol. Cancer Ther., October 1, 2008; 7(10): 3363 - 3372. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ramesh, S. A. Walker, D. B. Hood, M. D. Guillen, K. Schneider, and E. H. Weyand Bioavailability and Risk Assessment of Orally Ingested Polycyclic Aromatic Hydrocarbons International Journal of Toxicology, September 1, 2004; 23(5): 301 - 333. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. I. T. Sihvo, T. Ruohtula, M. I. Auvinen, A. Koivistoinen, A. L. Harjula, and J. A. Salo Simultaneous progression of oxidative stress and angiogenesis in malignant transformation of Barrett esophagus J. Thorac. Cardiovasc. Surg., January 1, 2004; 126(6): 1952 - 1957. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. H. Phillips Smoking-related DNA and protein adducts in human tissues Carcinogenesis, December 1, 2002; 23(12): 1979 - 2004. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Duell, E. A. Holly, P. M. Bracci, J. K. Wiencke, and K. T. Kelsey A Population-based Study of the Arg399Gln Polymorphism in X-Ray Repair Cross- Complementing Group 1 (XRCC1) and Risk of Pancreatic Adenocarcinoma Cancer Res., August 15, 2002; 62(16): 4630 - 4636. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. W. L. Godschalk, D. E. M. Feldker, P. J. A. Borm, E. F. M. Wouters, and F.-J. Van Schooten Body Mass Index Modulates Aromatic DNA Adduct Levels and Their Persistence in Smokers Cancer Epidemiol. Biomarkers Prev., August 1, 2002; 11(8): 790 - 793. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Duell, E. A. Holly, P. M. Bracci, M. Liu, J. K. Wiencke, and K. T. Kelsey A Population-Based, Case-Control Study of Polymorphisms in Carcinogen-Metabolizing Genes, Smoking, and Pancreatic Adenocarcinoma Risk J Natl Cancer Inst, February 20, 2002; 94(4): 297 - 306. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. Michaud, E. Giovannucci, W. C. Willett, G. A. Colditz, M. J. Stampfer, and C. S. Fuchs Physical Activity, Obesity, Height, and the Risk of Pancreatic Cancer JAMA, August 22, 2001; 286(8): 921 - 929. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Zhang, D. L. Weddle, P. E. Thomas, B. Zheng, A. Castonguay, H. M. Schuller, and M. S. Miller Low Levels of Expression of Cytochromes P-450 in Normal and Cancerous Fetal Pancreatic Tissues of Hamsters Treated with NNK and/or Ethanol Toxicol. Sci., August 1, 2000; 56(2): 313 - 323. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |